Skip to main content
. 2022 Jan 26;8:806911. doi: 10.3389/fmed.2021.806911

Table 1.

Characteristics of the study sample.

n 88
Age, years, median (IQR) 10.00 (4.00)
Range 6–16
Gender: Male 59 (67.05)
Height, cm 143.78 ± 16.39
Weight, kg 41.76 ± 16.64
BMI (kg/m2) 19.49 ± 4.51
Parental history of rhinitis (Y/N) 52 (59.09)
Parental education (>8 years) 69 (79.31)
Crowding Index
  0 1 (1.16)
  1 42 (48.84)
  ≥2 43 (50.00)
Indoor exposure in the last 12 months* (Y/N) 37 (42.53)
Outdoor exposure in the last 12 months§ (Y/N) 58 (66.67)
ARIA classes
  Mild Intermittent 20 (22.73)
  Moderate-severe intermittent 28 (31.82)
  Mild persistent 5 (5.68)
  Moderate-severe persistent 35 (39.77)
Disease duration, years 3.94 ± 3.34
Comorbidities
  Allergic conjunctivitis 15 (17.44)
  Primary snoring 33 (37.93)
SPT wheal size (mm), median (range)## 4 (3–12)
Nasal parameters
Log nNO, ppb 6.76 ± 1.10
Nasal cytology
  Log Eosinophils −0.91 ± 3.08
  Eosinophils 4.06 ± 6.18
  Log Neutrophils −2.47 ± 3.50
  Neutrophils 7.26 ± 13.11
  Log Mast cells −2.64 ± 2.91
  Mast cells 7.28 ± 0.23
Nasal pH 7.28 ± 0.23
IL-5 pg/ml 10.43 ± 11.48
IL-17 pg/ml 1.44 ± 2.50
IL-23 pg/ml 7.08 ± 4.08
IFN-γ pg/ml 6.49 ± 3.64
Subjective measurements
Nasal symptoms 3.49 ± 1.52
Eye symptoms 2.51 ± 1.59
Practical problems 3.26 ± 1.63
Activity limitation 2.82 ± 1.38
Other symptoms 2.53 ± 1.33
PRQLQ total score 2.92 ± 1.28
Sleep disturbance 2.33 ± 0.47
Sleep latency 0.82 ± 0.90
Day dysfunction due to sleepiness 0.49 ± 0.68
Sleep efficiency 1.00 ± 1.31
Self-rated sleep quality 0.94 ± 0.84
Need of medication to sleep 0.36 ± 0.94
PSQI total score 5.95 ± 2.35
T5SS 8.56 ± 3.50
T5SS ≥6 64 (80.00)

Data are presented as n (%) or as mean ± SD.

Lifetime;

*

Exposure to mold/pets/smoke.

§

Exposure to traffic at residential address.

##

Wheal and flare were measured, and saline-glycerin wheal size was subtracted from the grass wheal size.

Missing data n = 8.

Y/N, Yes or No; BMI, Body Mass Index; ARIA, Allergic Rhinitis and its Impact on Asthma; SPT, Skin Prick Test; nNO, nasal Nitric Oxide; PRQLQ, Pediatric Rhinoconjunctivitis Quality of Life Questionnaire; PSQI, Pittsburgh Sleep Quality Index; T5SS, Total 5 Symptom Score.